9069 Results

Congress Abstract

Prognostic value of SVZ involvement in relation to tumor volume defined by MRI and FET PET in GBM

Authors: Harat|, Maciej(1)*[haratm@co.bydgoszcz.pl];Małkowski|, Bogdan(2);Makarewicz|, Roman(1);
(1)Collegium Medicum Nicolaus Copernicus University, Oncology and Brachytherapy, Bydgoszcz, Poland;(2)Franciszek Lukaszyk Memorial Oncology Center, Nuclear Medicine, Bydgoszcz, Poland;
Show Affiliations

Congress Abstract

Low-dose radiotherapy (4 Gy) in the treatment of marginal zone B- cell lymphomas

Authors:

Marzia Cerrato1, Erika Orlandi1, Angelisa Vella1, Sara Bartoncini1, Giuseppe Carlo Iorio1, Diego Bongiovanni1, Francesco Capriotti1, Carola Boccomini2, Francesco Vassallo2, Chiara Cavallin1, Viola De Luca1, Francesca Romana Giglioli3, Umberto Ricardi1, Mario Levis1

1University of Torino, Department of Oncology, Torino, Italy; 2Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Hematology Unit, Torino, Italy; 3Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Medical Physics Unit, Torino, Italy

Show Affiliations

Congress Abstract

A multi-sensor-based dosimetry platform for real time source tracking in HDR brachytherapy

Authors:

HAYDEE MARIA LINARES ROSALES1, Jacob Johansen2, Gustavo Kertzscher2, Kari Tanderup2, Luc Beaulieu3, Sam Beddar4

1CHU de Québec - Université Laval, Physics, Québec, Cuba; 2Aarhus University Hospital, Oncology, Aarhus, Denmark; 3CHU de Québec - Université Laval, Physics, Québec, Canada; 4The University of Texas MD Anderson Cancer Center, Oncology, Houston, USA

Show Affiliations

Journal Article

Association between radiotherapy protocol variations and outcome in the CONVERT trial

Authors: Romaana Mir, Nicki Groom, Hitesh B. Mistry, Elena Wilson, Corinne Faivre-Finn

Congress Abstract

Prospective evaluation of robotic radiosurgery in Indian patients with oligo-metastases

Authors:

Ramakrishna Kamath1, Sruthi K1, Ajinkya Gupte1, Yarlagadda Sreenija1, Pushpaja K U1, Anoop R1, Ajay Sasidharan2, Haridas Nair1, Annex E H3, Debnarayan Dutta1

1Amrita Institute of Medical Sciences, Radiation Oncology, Kochi, India; 2Amrita Institute of Medical Sciences, Radiation oncology, Kochi, India; 3Amrita Institute of Medical Sciences, Medical Physics, Kochi, India

Show Affiliations

Congress Abstract

HDR Prostate Brachytherapy – Is 20 needles too many?

Authors:

Jennifer Wilson1, Anna Lydon2, Lauren Rowberry1, Charlotte Trewin3

1Royal Devon & Exeter NHS Foundation Trust, Radiotherapy Physics, Exeter, United Kingdom; 2Torbay and South Devon NHS Foundation Trust, Oncology, Torquay, United Kingdom; 3Royal Devon & Exeter NHS Foundation Trust, Oncology, Exeter, United Kingdom

Show Affiliations

Congress Abstract

Risk factors for late brain lesions in proton treated glioma patients: ventricular proximity and RBE

Authors: Bahn|, Emanuel(1,2,3,4)*[em.bahn@gmail.com];Bauer|, Julia(1,2,3);Harrabi|, Semi(1,2,3);Herfarth|, Klaus(1,2,3);Debus|, Jürgen(1,2,3,4);Alber|, Markus(1,2,3);
(1)Heidelberg University Hospital, Radiation Oncology, Heidelberg, Germany;(2)Heidelberger Institut für Radioonkologie HIRO, Quantitative klinische Strahlenbiologie, Heidelberg, Germany;(3)National Center for Tumor Diseases NCT, Integrative Radiation Oncology, Heidelberg, Germany;(4)German Cancer Research Center DKFZ, Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany;
Show Affiliations

Congress Abstract

The influence of telomere length on mortality in prostate cancer patients treated with radiotherapy.

Authors: Langsenlehner , Tanja(1)[tanja.langsenlehner@klinikum-graz.at];Lukasiak , Katarzyna(2)*;Thurner , Eva-Maria(2);Langsenlehner , Uwe(3);Stranzl-Lawatsch , Heidi(2);Renner , Wilfried(4);
(1)Medical University of Graz, Department of Radiation Oncology, Graz, Austria;(2)Medical University of Graz, Department of Therapeutic Radiology and Oncology, Graz, Austria;(3)FÄZ Graz, Department of Internal Medicine, Graz, Austria;(4)Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria;
Show Affiliations

Congress Abstract

Oligorecurrent prostate cancer treated with metastasis-directed therapy: oncological outcomes

Authors: Devos|, Gaetan(1);Berghen|, Charlien(2)*[conkeytje@hotmail.com];Joniau|, Steven(1);Poels|, Kenneth(2);Haustermans|, Karin(2);Rans|, Kato(2);De Meerleer|, Gert(2);
(1)University Hospital Gasthuisberg, Urology, Leuven, Belgium;(2)University Hospital Gasthuisberg, Radiation Oncology, Leuven, Belgium;
Show Affiliations
*:*